Prevalence of aortic dilation in hypertrophic cardiomyopathy.

about

Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging).

P2860

Q35197381-ED289F45-FF3E-4FC1-A0FC-377DB3FF5AB2 Q35831475-FF3313B9-BD78-4400-A6A2-527E429E4AAB

P2860

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

Item

http://www.wikidata.org/entity/Q36931270

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

@en

type

Item

label

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

@en

prefLabel

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

@en

P1476

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

@en

P2093

Adam Helms

http://www.w3.org/2001/XMLSchema#string

Anna M Booher

http://www.w3.org/2001/XMLSchema#string

Renuka Jain

http://www.w3.org/2001/XMLSchema#string

Sharlene M Day

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

A formula to estimate the approximate surface area if height and weight be known. 1916.

Recommendations for chamber quantification.

Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis

Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.

Thoracic aortic aneurysm clinically pertinent controversies and uncertainties.

Molecular genetic studies of familial hypertrophic cardiomyopathy.

P304

79-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23785585

http://www.w3.org/2001/XMLSchema#string

P932

3683405

http://www.w3.org/2001/XMLSchema#string

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

about

P2860

P2860

Prevalence of aortic dilation in hypertrophic cardiomyopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932